Home » Research » Predictors of outcome in 176 South African patients with peripartum cardiomyopathy

Predictors of outcome in 176 South African patients with peripartum cadiomyopathy

Menu

• Research
  • Heart failure with reduced ejection fraction and atrial fibrillation: a Sub-Saharan African perspective
  • Forgotten cardiovascular disease in Africa
  • Burden of Heart Failure in Soweto
  • Heart of Soweto Study Published
  • Heart of Soweto Study
  • Acute Heart Failure Registry
  • Peripartum Cardiomyopathy
  • Peripartum Cardiomyopathy: Position Statement
  • Peripartum Cardiomyopathy: Seminar
  • Hypertension: A Global Perspective
  • Advanced heart disease in Soweto
  • Anaemia and renal function in heart failure
  • Stem cells
  • Heart Regeneration
  • The Causes, Treatment, and Outcome of Acute Heart Failure
  • Readmission and death after an acute heart failure event
  • Gender differences in clinical characteristics and outcome of acute heart failure in Sub-Saharan Africa
  • Renal dysfunction in African patients with acute heart failure
  • Heart failure in low and middle income countries
  • Contemporary profile of acute heart failure in Southern Nigeria
  • The burden of heart failure in Africa
  • A predominance of hypertensive heart failure in the Abuja heart study cohort of Urban Nigerians
  • Renal dysfunction in African patients with acute heart failure
  • Pathophysiology and epidemiology of peripartum cardiomyopathy
  • Economic burden of heart failure: Investigating outpatient and inpatient costs in Abeokuta, South West Nigeria
  • Short-term outcomes after hospital discharge in patients admitted with heart failure
  • Hypertensive heart failure in Nigerian Africans: Insights from the Abeokuta heart failure registry
  • Predictors of outcome in 176 South African patients with peripartum cardiomyopathy
  • Management of valvular disease in pregnancy: a global perspective
  • Global Chronic Heart Failure Registry (G-CHF)
  • Global Chronic Heart Failure Registry (G-CHF)

Newsletter

Subscribe to our newsletter